Clinical Trial Update: 50/50% Tilt and Tuned Defibrillation Waveform [NA]

View source ↗

Summary

A completed clinical trial sponsored by Abbott Medical Devices evaluated a 50/50% tilt and tuned defibrillation waveform for defibrillation testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmias
• Sudden Cardiac Death
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• 50/50% Tilt and Tuned Defibrillation Waveform

Snippet

Sponsor: Abbott Medical Devices | Conditions: DFT Testing | NA | Status: COMPLETED